Latest News and Press Releases
Want to stay updated on the latest news?
-
Capricor Therapeutics Shareholders Between December 17, 2025 and July 6, 2026 - Contact Bernstein Liebhard For More Information Regarding Lawsuit
-
Investors who lost money in CAPR after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Capricor Therapeutics investors should submit their transactions to Block & Leviton for a complimentary case review amid securities fraud investigation.
-
Block & Leviton announces that a securities fraud lawsuit has been filed against Capricor Therapeutics (Nasdaq: CAPR). Investors should contact the firm.